(Q36168171)

English

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

0 references

author name string

Carl Dahlöf

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Elizabeth Loder

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Merle Diamond

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Marcia Rupnow

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

George Papadopoulos

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lian Mao

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 October 2007

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Health and Quality of Life Outcomes

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

56

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

4 October 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

1 October 2017

MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

2 July 2018

Migraine prevalence, disease burden, and the need for preventive therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Topiramate improves health-related quality of life when used to prevent migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Topiramate in migraine prevention: results of a large controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Topiramate for migraine prevention: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

The impact of migraine on quality of life in the general population: the GEM study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2093930

23 September 2018

Development and validation of the Migraine-Specific Quality of Life Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/17916258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the ability of topiramate to improve the daily activities of patients with migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17916258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of migraine on daily activities: effect of topiramate compared with placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17916258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1477-7525-5-56

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

release_wzibg57d2ja5rdki5vrnagvvsm

1 reference

https://api.fatcat.wiki/v0/release/wzibg57d2ja5rdki5vrnagvvsm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36168171&oldid=2198290761"